DiappyMed specializes in developing platforms to calculate insulin dosages.
DiappyMed has raised $5.8M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
DiappyMed's investors include Ventech, AFI Ventures, IRDI SORIDEC Gestion, Sofilaro.
DiappyMed is headquartered in Clapiers, France.
DiappyMed specializes in developing platforms to calculate insulin dosages.
DiappyMed is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DiappyMed — Funding & Investors." VCBacked, March 22, 2026, https://www.vcbacked.co/company/diappymed. Accessed August 22, 2026.
VCBacked. (2026). DiappyMed — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/diappymed
{{cite web |title=DiappyMed — Funding & Investors |url=https://www.vcbacked.co/company/diappymed |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated